2024肺癌ASCO必威体育精装版进展之NRG-LU002Randomized Phase lllll Trial Of MaintenanceSystemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer.pdf

2024肺癌ASCO必威体育精装版进展之NRG-LU002Randomized Phase lllll Trial Of MaintenanceSystemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer.pdf

  1. 1、本文档共25页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多

Slide1

Contentofthispresentationisthepropertyoftheauthor,licensedbyASCO.Permissionrequiredforreuse.

Slide2

Contentofthispresentationisthepropertyoftheauthor,licensedbyASCO.Permissionrequiredforreuse.

Slide3

Contentofthispresentationisthepropertyoftheauthor,licensedbyASCO.Permissionrequiredforreuse.

Slide4

Contentofthispresentationisthepropertyoftheauthor,licensedbyASCO.Permissionrequiredforreuse.

Slide5

Contentofthispresentationisthepropertyoftheauthor,licensedbyASCO.Permissionrequiredforreuse.

Slide6

Contentofthispresentationisthepropertyoftheauthor,licensedbyASCO.Permissionrequiredforreuse.

Slide7

Contentofthispresentationisthepropertyoftheauthor,licensedbyASCO.Permissionrequiredforreuse.

Methods–Schema,Eligibility,andEnrollment

Contentofthispresentationisthepropertyoftheauthor,licensedbyASCO.Permissionrequiredforreuse.

Methods–PrimaryandSecondaryObjectives

Contentofthispresentationisthepropertyoftheauthor,licensedbyASCO.Permissionrequiredforreuse.

Methods–PrimaryHypothesis

Contentofthispresentationisthepropertyoftheauthor,licensedby

您可能关注的文档

文档评论(0)

提供肿瘤指南资料、指导自然科研立项、各类文案设计、文章翻译润色、PPT制作等相关服务,可咨询QQ:731689706

1亿VIP精品文档

相关文档